ArticleJTCVS open2025
Extracorporeal cardiopulmonary resuscitation in Medicare recipients.
Article in JTCVS open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Objective: The use of extracorporeal cardiopulmonary resuscitation (ECPR) in older patients is a controversial practice. The historically high mortality associated with elderly patients who require extracorporeal support frequently dampens the enthusiasm for expending limited, cost-intensive resources on patients of advanced age. We evaluated outcomes in Medicare patients who had suffered sudden acute cardiac arrest and received extracorporeal support. Methods: We used the United States Medicare Inpatient Analytical Files (2018-2023) to evaluate beneficiaries with cardiac arrest who were placed on venoarterial extracorporeal membrane oxygenation (VA-ECMO). International Classification of Diseases, Tenth Revision codes were used to define comorbidities and frailty using validated metrics. Results: Of the 5810 Medicare beneficiaries who were placed on VA-ECMO, 1174 experienced cardiac arrest during the same admission and were categorized as the "ECPR cohort." Their mean Charlson Comorbidity Index score was 2.66 ± 1.36. Approximately one-third had a history of diabetes, liver disease, and chronic renal failure; 52.9% had coronary artery disease, and 65.4% had heart failure. Mortality during hospitalization was 63.8%. Age-stratified 5-year mortality was 69.8% in patients age <70, 78.0% in those age 71% to 80%, and 86.8% in those age >80 years. Conditional on surviving to discharge, mortality was ∼10% at both 1 year and 5 years. Conclusions: The use of ECPR in Medicare recipients is characterized by high mortality, which further increases with age. This real-world report may help guide the complex clinical decision making in the resuscitation of elderly patients who suffer cardiac arrest.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.